|
|
Volumn 20, Issue 4, 2010, Pages 425-429
|
|
Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct
|
|
Author keywords
CXCL12; CXCR4; Glioblastoma; Homing; Hypoxic; Plerixator
|
|
Indexed keywords
ANTIFUNGAL AGENT;
CHEMOKINE RECEPTOR CXCR4;
CLOTRIMAZOLE;
CXCR4 PROTEIN, HUMAN;
DRUG DERIVATIVE;
HETEROCYCLIC COMPOUND;
HISTAMINE H1 RECEPTOR ANTAGONIST;
MIANSERIN;
MIRTAZAPINE;
PLERIXAFOR;
BRAIN TUMOR;
DRUG EFFECT;
DRUG POTENTIATION;
GLIOBLASTOMA;
HUMAN;
METABOLISM;
REVIEW;
SIGNAL TRANSDUCTION;
|
|
EID: 77958544067
PISSN: 10195149
EISSN: None
Source Type: Journal
DOI: 10.5137/1019-5149.JTN.3334-10.0 Document Type: Short Survey |
|
Times cited : (18)
|
|
References (42)
|
